Chescapmanager LLC Theravance Biopharma, Inc. Transaction History

Chescapmanager LLC

$913 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$8.29 - $9.92 $871,842 - $1.04 Million	-105,168 Reduced 52.23%	96,197 $815,000
Q1 2024 May 15, 2024	SELL	$8.22 - $11.59 $233,472 - $329,190	-28,403 Reduced 12.36%	201,365 $1.81 Million
Q4 2023 Feb 14, 2024	SELL	$8.58 - $11.4 $493,907 - $656,241	-57,565 Reduced 20.03%	229,768 $2.58 Million
Q2 2023 Aug 14, 2023	SELL	$10.16 - $11.92 $3.41 Million - $4 Million	-335,405 Reduced 53.86%	287,333 $2.97 Million
Q1 2023 May 15, 2023	SELL	$9.87 - $11.44 $2.25 Million - $2.61 Million	-228,250 Reduced 26.82%	622,738 $6.76 Million
Q4 2022 Feb 14, 2023	SELL	$9.65 - $11.34 $2.99 Million - $3.51 Million	-309,515 Reduced 26.67%	850,988 $9.55 Million
Q2 2022 Aug 12, 2022	SELL	$8.41 - $10.34 $51,057 - $62,774	-6,071 Reduced 0.52%	1,160,503 $10.5 Million
Q1 2022 May 13, 2022	SELL	$8.33 - $12.96 $792,183 - $1.23 Million	-95,100 Reduced 7.54%	1,166,574 $11.2 Million
Q4 2021 Feb 11, 2022	SELL	$7.42 - $11.05 $4.68 Million - $6.97 Million	-630,778 Reduced 33.33%	1,261,674 $13.9 Million
Q3 2021 Nov 15, 2021	BUY	$6.77 - $14.41 $4.27 Million - $9.09 Million	630,734 Added 49.99%	1,892,452 $14 Million
Q2 2021 Aug 16, 2021	BUY	$14.52 - $22.46 $1.84 Million - $2.85 Million	127,000 Added 11.19%	1,261,718 $18.3 Million
Q4 2020 Feb 12, 2021	SELL	$14.89 - $20.16 $342,470 - $463,680	-23,000 Reduced 1.99%	1,134,718 $20.2 Million
Q3 2020 Nov 16, 2020	BUY	$14.79 - $22.49 $887,400 - $1.35 Million	60,000 Added 5.47%	1,157,718 $17.1 Million
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $1.96 Million - $2.92 Million	95,000 Added 9.47%	1,097,718 $23 Million
Q1 2020 May 15, 2020	BUY	$17.84 - $31.21 $958,222 - $1.68 Million	53,712 Added 5.66%	1,002,718 $23.2 Million
Q4 2019 Feb 12, 2020	BUY	$16.12 - $25.89 $5.66 Million - $9.1 Million	351,422 Added 58.81%	949,006 $24.6 Million
Q3 2019 Nov 14, 2019	BUY	$16.51 - $23.78 $806,265 - $1.16 Million	48,835 Added 8.9%	597,584 $11.6 Million
Q2 2019 Aug 14, 2019	BUY	$15.6 - $25.15 $1.56 Million - $2.51 Million	99,885 Added 22.25%	548,749 $8.96 Million
Q1 2019 May 15, 2019	BUY	$22.57 - $28.15 $766,093 - $955,495	33,943 Added 8.18%	448,864 $10.2 Million
Q4 2018 Feb 13, 2019	BUY	$22.52 - $35.07 $135,120 - $210,420	6,000 Added 1.47%	414,921 $10.6 Million
Q3 2018 Nov 14, 2018	BUY	$22.83 - $32.67 $127,847 - $182,952	5,600 Added 1.39%	408,921 $13.4 Million
Q2 2018 Aug 10, 2018	BUY	$22.06 - $25.52 $1.16 Million - $1.34 Million	52,690 Added 15.03%	403,321 $9.15 Million
Q1 2018 May 14, 2018	BUY	$23.37 - $29.71 $1.35 Million - $1.71 Million	57,614 Added 19.66%	350,631 $8.5 Million
Q4 2017 Feb 14, 2018	BUY	$25.82 - $35.66 $296,413 - $409,376	11,480 Added 4.08%	293,017 $8.17 Million
Q3 2017 Nov 13, 2017	BUY	$23.88 - $34.96 $1.44 Million - $2.11 Million	60,420 Added 27.32%	281,537 $9.64 Million
Q2 2017 Aug 14, 2017	BUY	N/A	221,117	221,117 $8.81 Million

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

Madison Avenue Partners, LP New York, NY

9.51M
Shares

$91.4 Million
9.44% of portfolio
Weiss Asset Management LP Boston, MA

7.46M
Shares

$71.7 Million
1.94% of portfolio
Newtyn Management, LLC New York, NY

4.5M
Shares

$43.2 Million
6.4% of portfolio
Black Rock Inc. New York, NY

3.78M
Shares

$36.3 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$26.5 Million
1.95% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $642M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chescapmanager LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chescapmanager LLC with notifications on news.

Account